Importantly, TRIM25 binding to caspase-2 mRNA was markedly increased after CRC cells were exposed to doxorubicin, which corresponded to a reduction in caspase-2 translation, and thus, implicates a novel mechanism which is relevant for both intrinsic as well as acquired chemoresistance [87]. The gene discussed is TRIM25; the disease is colorectal carcinoma.